Patent assignee · US · COMPANY

Juno Therapeutics, Inc.

🏢 View company profile →
65Patents
65Active
65Granted
55Portfolio score

Filing activity: Feb 25, 2013 → Dec 16, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US11400115B2 Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy Emerging Cross-Sectional Technologies 11 Active
US10228312B2 Chromatographic isolation of cells and other complex biological materials Physics 11 Active
US11413310B2 Articles of manufacture and methods for treatment using adoptive cell therapy Human Necessities 10 Active
US10533055B2 Antibodies and chimeric antigen receptors specific for CD19 Chemistry; Metallurgy 9 Active
US11020429B2 Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy Chemistry; Metallurgy 6 Active
US11466253B2 Methods for culturing cells and kits and apparatus for same Chemistry; Metallurgy 6 Active
US10428351B2 Methods for transduction and cell processing Chemistry; Metallurgy 6 Active
US11066475B2 Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides Chemistry; Metallurgy 5 Active
US11248238B2 Methods, kits, agents and apparatuses for transduction Chemistry; Metallurgy 5 Active
US11274278B2 Methods, kits and apparatus for expanding a population of cells Chemistry; Metallurgy 5 Active
US10363269B2 Modified hepatitis post-transcriptional regulatory elements Chemistry; Metallurgy 5 Active
US10738278B2 Engineered cells for adoptive cell therapy Chemistry; Metallurgy 4 Active
US10889652B2 Antibodies and chimeric antigen receptors specific for ROR1 Chemistry; Metallurgy 3 Active
US10507219B2 Methods and compositions for dosing in adoptive cell therapy Chemistry; Metallurgy 3 Active
US11866465B2 Oligomeric particle reagents and methods of use thereof Chemistry; Metallurgy 3 Active
US11944647B2 Articles of manufacture and methods for treatment using adoptive cell therapy Human Necessities 2 Active
US11815514B2 Methods and compositions related to toxicity associated with cell therapy Chemistry; Metallurgy 2 Active
US11623961B2 Antibodies and chimeric antigen receptors specific for B-cell maturation antigen Chemistry; Metallurgy 2 Active
US11851678B2 Methods for producing genetically engineered cell compositions and related compositions Physics 2 Active
US10786533B2 Engineered cells for adoptive cell therapy Chemistry; Metallurgy 2 Active
US11072660B2 HPV-specific binding molecules Chemistry; Metallurgy 2 Active
US11913024B2 Methods for culturing cells and kits and apparatus for same Chemistry; Metallurgy 2 Active
US11564946B2 Methods associated with tumor burden for assessing response to a cell therapy Physics 2 Active
US11919970B2 Antibodies and chimeric antigen receptors specific for ROR1 Chemistry; Metallurgy 1 Active
US11421287B2 Methods for assessing the presence or absence of replication competent virus Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.